论文部分内容阅读
目的:观察阿托伐他汀对急性冠脉综合征(ACS)患者血脂、预后的影响。方法:将72例ACS患者随机分为治疗组(42例)和对照组(30例),观察其血脂、心脏事件在治疗前后的情况。结果:治疗组治疗后血脂明显下降(P<0.05),与对照组治疗后比较P<0.05;与对照组比较,治疗组治疗后心脏事件发生率明显下降(P<0.05);两组治疗前后无明显不良反应。结论:ACS患者应用阿托伐他汀可以改善预后。
Objective: To observe the effect of atorvastatin on blood lipid and prognosis in patients with acute coronary syndrome (ACS). Methods: Seventy-two ACS patients were randomly divided into treatment group (n = 42) and control group (n = 30). The levels of blood lipids and cardiac events before and after treatment were observed. Results: Compared with the control group, the blood lipids in the treatment group decreased significantly (P <0.05), compared with the control group (P <0.05). The incidence of cardiac events in the treatment group decreased significantly after treatment (P <0.05) No obvious adverse reactions. Conclusions: The use of atorvastatin in patients with ACS can improve the prognosis.